Crescentis Capital has finalized terms for a Rs 79.62 crore rights issue, offering shareholders 3 new shares for every 5 held at Rs 78 apiece. The record date is set for November 4, 2026.
Crescentis Capital Announces Rs 79.62 Crore Rights Issue
Total Rights Equity Shares: 1,02,08,129 shares.
Issue Price: Rs 78 per share.
Reader Takeaway: Existing shareholders gain access to discounted shares; equity base expands post-subscription potentially impacting earnings per share.
What just happened
The Fund Raising Committee of Crescentis Capital Limited has approved the definitive terms for its upcoming rights issue to raise Rs 79.62 crore. The company will issue 1,02,08,129 new equity shares at a price of Rs 78 each, which includes a premium of Rs 68 over the Rs 10 face value.
Why this matters
This capital infusion will expand the company's equity base from 1,70,13,549 shares to 2,72,21,678 shares, assuming full subscription. Shareholders who remain on the company's register by the record date of November 4, 2026, are entitled to participate in the offer at a ratio of 3 shares for every 5 existing shares held.
Rights Issue Timeline
- Issue Opening Date: November 16, 2026
- On-market Renunciation Start: November 16, 2026
- On-market Renunciation End: November 20, 2026
- Issue Closing Date: November 27, 2026
Key Considerations for Shareholders
Investors with fractional entitlements—those holding fewer than 5 shares—will have those fractions ignored. However, the company provides a mechanism for these investors to apply for additional shares, which will receive preferential consideration subject to availability. Shareholders should also note that rights entitlements can be renounced off-market, provided they are credited to the renouncee's demat account by the closing date.
What to track next
Investors should monitor the Letter of Offer for specific details regarding the intended deployment of the Rs 79.62 crore. Understanding how this capital will be used to drive growth or deleverage the balance sheet will be key to evaluating the long-term benefit of participating in this issue.
